GSK-2256098
Catalog No: 16123011
CAS Number: 1224887-10-8
Purity: 98%
GSK2256098, also known as GTPL7939, is a focal adhesion kinase-1 (FAK) inhibitor with potential antiangiogenic and antineoplastic activities. FAK inhibitor GSK2256098 inhibits FAK, which may prevent the integrin-mediated activation of several downstream signal transduction pathways, including ERK, JNK/MAPK and PI3K/Akt, thereby inhibiting tumor cell migration, proliferation and survival, and tumor angiogenesis. The tyrosine kinase FAK is normally activated by binding to integrins in the extracellular matrix (ECM) but may be upregulated and constitutively activated in various tumor cell types.
For research use only. We do not sell to patients.
Chemical Information
| Name | GSK-2256098 |
|---|---|
| Iupac Chemical Name | GSK-2256098 |
| Synonyms | GSK2256098; GSK 2256098; GSK-2256098; GTPL7939; GTPL-7939; GTP L7939 |
| Molecular Formula | C20H23ClN6O2 |
| Molecular Weight | 414.894 |
| InChiKey | |
| InChi | |
| CAS Number | 1224887-10-8 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | crystalline solid |
|---|---|
| Purity | 98% |
| Storage | 3 years -20ºCpowder |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
